Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Delayed Canadian Securities Exchange
Other stock markets
 10:01:00 2024-12-05 am EST 		5-day change 1st Jan Change
0.1400 CAD 0.00% Intraday chart for Entheon Biomedical Corp. +3.70% +40.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI

Business description: Entheon Biomedical Corp.

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.

Number of employees: 1

Sales by Activity: Entheon Biomedical Corp.

Fiscal Period: November20192020202120222023

Acquisition, Exploration and Development of Mining Properties

- - 21.67K 190K 250K
See all business segments

Geographical breakdown of sales: Entheon Biomedical Corp.

Fiscal Period: November20192020202120222023

Canada

- - 21.67K 190K 250K
See all geographic segments

Managers: Entheon Biomedical Corp.

Director TitleAgeSince
Timothy Ko CEO
 Chief Executive Officer 39 2019-06-30
Soo-Whan Kim DFI
 Director of Finance/CFO - 2023-01-06
Joseph Cullen IRC
 Investor Relations Contact 41 2019-04-30
Kelly Pladson SEC
 Corporate Secretary 42 -
Jonna Birgans PRN
 Corporate Officer/Principal - 2021-02-03
See ENTHEON BIOMEDICAL CORP. governance

Members of the board: Entheon Biomedical Corp.

Manager TitleAgeSince
Timothy Ko BRD
 Director/Board Member 39 2020-11-04
Andrew Hegle BRD
 Director/Board Member 46 2020-11-04
Christopher Gondi BRD
 Director/Board Member 53 2020-11-04
Composition of the Board of Directors

Shareholders: Entheon Biomedical Corp.

NameEquities%Valuation
Canal Front Investments, Inc.
8.579 %
760,000 8.579 % 63 840 $
Timothy Ko
2.596 %
230,000 2.596 % 19 320 $
Christopher Gondi
0.5644 %
50,000 0.5644 % 4 200 $
Andrew Hegle
0.1129 %
10,000 0.1129 % 840 $
List of ENTHEON BIOMEDICAL CORP. shareholders

Company details: Entheon Biomedical Corp.

Entheon Biomedical Corp.

999 West Broadway Suite 720

V5Z 1K5, Vancouver

+

http://www.entheonbiomedical.com
address Entheon Biomedical Corp.(ENBI)

Other Biotechnology & Medical Research

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
ENTHEON BIOMEDICAL CORP. Stock Entheon Biomedical Corp.
0.00%+3.70%+40.00%-96.96%881K
LONZA GROUP AG Stock Lonza Group AG
-1.78%-0.27%+55.48%-26.51%43.21B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.57%-0.21%-6.48%-23.83%36.88B
CELLTRION, INC. Stock Celltrion, Inc.
-1.09%+1.80%+11.32%-8.79%26.71B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
-1.50%+0.14%-21.88%-20.83%17.71B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
-0.46%+0.96%+55.64%+98.19%16.71B
MODERNA, INC. Stock Moderna, Inc.
+2.50%-0.05%-45.02%-83.78%16.02B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-1.45%-0.17%+16.86%-35.73%12.06B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
-2.60%-1.34%+21.40%+63.94%10.74B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.10%-1.61%-1.25%-44.26%10.19B
Average -1.00%-0.08%+12.61%-17.85% 19.02B
Weighted average by Cap. -1.18%+0.07%+14.21%-13.27%
See all sector performances

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Income Statement and Estimates

income-statement-evolution-chart ENTHEON-BIOMEDICAL-CORP More financial data
  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. Company Entheon Biomedical Corp.